Tona, F.; Zanatta, E.; Montisci, R.; Muraru, D.; Beccegato, E.; De Zorzi, E.; Benvenuti, F.; Civieri, G.; Cozzi, F.; Iliceto, S.;
et al. Higher Ventricular-Arterial Coupling Derived from Three-Dimensional Echocardiography Is Associated with a Worse Clinical Outcome in Systemic Sclerosis. Pharmaceuticals 2021, 14, 646.
https://doi.org/10.3390/ph14070646
AMA Style
Tona F, Zanatta E, Montisci R, Muraru D, Beccegato E, De Zorzi E, Benvenuti F, Civieri G, Cozzi F, Iliceto S,
et al. Higher Ventricular-Arterial Coupling Derived from Three-Dimensional Echocardiography Is Associated with a Worse Clinical Outcome in Systemic Sclerosis. Pharmaceuticals. 2021; 14(7):646.
https://doi.org/10.3390/ph14070646
Chicago/Turabian Style
Tona, Francesco, Elisabetta Zanatta, Roberta Montisci, Denisa Muraru, Elena Beccegato, Elena De Zorzi, Francesco Benvenuti, Giovanni Civieri, Franco Cozzi, Sabino Iliceto,
and et al. 2021. "Higher Ventricular-Arterial Coupling Derived from Three-Dimensional Echocardiography Is Associated with a Worse Clinical Outcome in Systemic Sclerosis" Pharmaceuticals 14, no. 7: 646.
https://doi.org/10.3390/ph14070646
APA Style
Tona, F., Zanatta, E., Montisci, R., Muraru, D., Beccegato, E., De Zorzi, E., Benvenuti, F., Civieri, G., Cozzi, F., Iliceto, S., & Doria, A.
(2021). Higher Ventricular-Arterial Coupling Derived from Three-Dimensional Echocardiography Is Associated with a Worse Clinical Outcome in Systemic Sclerosis. Pharmaceuticals, 14(7), 646.
https://doi.org/10.3390/ph14070646